Tags : Patents

Amgen Reports In-Favor Uphold of its Two Patents for Repatha

Shots: Amgen receives in-favor upholding validity for Repatha from Delaware Jury, with two out of five asserted claims based on its patents meeting the legal requirements of written description and enablement In Mar,2016 Sanofi and Regeneron admitted infringement of Amgen’s patents, regaining Amgen with two patents of Repatha but was overturned on appeal in the […]Read More